FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
Notably absent from the Park Board meeting, however, were complete findings from a monthslong audit into the landmark’s ...
(NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the expanded approval of ...
Synergy Medical Associates is a primary care office that provides internal medicine care for patients 15 and older.
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
35m
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback